YE

Yaniv Erlich

Chief Executive Officer

Eleven Therapeutics

London, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Eleven Therapeutics
Industry
research
Employees
29.0
Seniority
C suite
Annual Revenue
2200000.0
Total Funding
25900000.0
Latest Funding
Seed

Technologies

Gmail Google Apps Microsoft Office 365 DigitalOcean reCAPTCHA Bootstrap Framework Google Analytics Google Tag Manager Nginx WordPress.org Mobile Friendly Remote AI

Keywords

rna therapeutics synthetic chemistry ai algorithms combinatorial chemistry mrna therapeutics chemical topology structure-activity relationship sar dna synthesis high-throughput sequencing therapeutic rna molecules chemical modifications rnai crispr technologies in vivo validation bioavailability immunogenicity targeted therapies gene therapy oligonucleotide therapeutics programmable therapeutics deep learning chemical synthesis therapeutic oligos rna modifications custom rna therapies biological revolution collaborative hubs chemical patterns cell-specific carriers digital design therapeutic efficacy safety optimization cost-effective synthesis data-driven drug development high throughput assays rna livraison diagnostic innovation biotech startups biotechnology rna delivery systems molecular biology r&d pipelines precision medicine partnerships biological data therapeutic gene silencing cellular biology molecular research artificial intelligence information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans